Key Facts

Invested since 2020
Based in International

About the company

Lymphatica Medtech develops medical devices for lymphatic disease treatment. The first product, LymphoDRAIN, is the worldwide first active lymphatic bypass for the treatment of chronic lymphedema, a disabling disease affecting millions of people worldwide.
Lymphatica developed its implantable drainage technology as a results of years of research at the Lausanne Federal Institute of Technology (EPFL) and of the Lausanne University Hospital (CHUV).

Do you want to

know more about this company?

Zum Artikel

Dr. Anke Caßing Principal

Dr. Anke CaßingPrincipal

Lymphatica in the news

Zum Artikel

News

8. October 2024

Lymphatica Medtech closes €17.9M Series B funding round to drive Innovation in Lymphedema Treatment

Triacca Valentina Zum Artikel

Story

16. November 2022

What have you learnt? Episode 3 with Lymphaticas Valentina Triacca

Zum Artikel

News

3. December 2020

Lymphatica Medtech raises seven-digit Series A round

More startups from Life Sciences